PubMed

Treatment of HIV infection: Swedish recommendations 2009.

Josephson F, Albert J, Flamholc L, Gisslén M, Karlström O, Moberg L, Navér L, Svedhem V, Svennerholm B, Sönnerborg A.

Scand J Infect Dis. 2009;41(11-12):788-807.PMID: 19922061 [PubMed - as supplied by publisher]Related articles

Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.

Mansour W, Ducancelle A, Le Gal F, Le Guillou-Guillemette H, Abgueguen P, Pivert A, Calès P, Gordien E, Lunel F.

J Clin Virol. 2009 Nov 12. [Epub ahead of print]PMID: 19914127 [PubMed - as supplied by publisher]Related articles

Gateways to clinical trials.

Tomillero A, Moral MA.

Methods Find Exp Clin Pharmacol. 2009 Sep;31(7):463-93.PMID: 19907722 [PubMed - in process]Related articles

Viral Load Decay in Antiretroviral-Naïve Patients Receiving Once-Daily Tenofovir and Emtricitabine plus Twice-Daily Nevirapine.

Amoroso A, Gilliam BL, Talwani R, Boyce C, Redfield RR, Davis CE.

HIV Clin Trials. 2009 Sep-Oct;10(5):320-3.PMID: 19906624 [PubMed - in process]Related articles

Viral hepatitis and HIV co-infection.

Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P.

Antiviral Res. 2009 Nov 1. [Epub ahead of print]PMID: 19887087 [PubMed - as supplied by publisher]Related articles

Intrapartum Tenofovir and Emtricitabine Reduces Low-Concentration Drug Resistance Selected by Single-Dose Nevirapine for Perinatal HIV Prevention.

Chi BH, Ellis GM, Chintu N, Cantrell RA, Sinkala M, Aldrovandi GM, Warrier R, Mbewe F, Nakamura K, Stringer EM, Frenkel LM, Stringer JS.

AIDS Res Hum Retroviruses. 2009 Nov 3. [Epub ahead of print]PMID: 19886836 [PubMed - as supplied by publisher]Related articles

[Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome]

Lavae-Mokhtari M, Mohammad-Khani S, Schmidt RE, Stoll M.

Med Klin (Munich). 2009 Oct 15;104(10):810-3. Epub 2009 Oct 25. German. PMID: 19856155 [PubMed - in process]Related articles

Safety and efficacy of telbivudine for the treatment of chronic hepatitis B.

Osborn MK.

Ther Clin Risk Manag. 2009;5:789-98. Epub 2009 Oct 12.PMID: 19851526 [PubMed - in process]Related articlesFree article

Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.

Martin A, Bloch M, Amin J, Baker D, Cooper DA, Emery S, Carr A.

Clin Infect Dis. 2009 Nov 15;49(10):1591-601.PMID: 19842973 [PubMed - in process]Related articles

Lower limb high arterial flow induced by tenofovir and emtricitabine treatment.

Periard D, Yerly P, Hayoz D, Mazzolai L, Widmeier A, Cavassini M.

Antivir Ther. 2009;14(6):865-7.PMID: 19812450 [PubMed - in process]Related articles

Gateways to clinical trials.

Tomillero A, Moral MA.

Methods Find Exp Clin Pharmacol. 2009 Jul-Aug;31(6):397-417.PMID: 19798455 [PubMed - in process]Related articles

Tenofovir for the treatment of hepatitis B virus.

Jenh AM, Thio CL, Pham PA.

Pharmacotherapy. 2009 Oct;29(10):1212-27.PMID: 19792994 [PubMed - in process]Related articles

Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.

Hill A, Sawyer W.

HIV Med. 2009 Oct;10(9):527-35.PMID: 19785663 [PubMed - in process]Related articles

On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors.

Kuklenyik Z, Martin A, Pau CP, Holder A, Youngpairoj AS, Zheng Q, Cong ME, Garcia-Lerma JG, Heneine W, Pirkle JL, Barr JR.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 1;877(29):3659-66. Epub 2009 Sep 11.PMID: 19783232 [PubMed - in process]Related articles

Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients.

Bickel M, Bodtländer A, Knecht GK, Stephan C, von Hentig N, Kurowski M, Gute P, Klauke S, Lutz T.

J Antimicrob Chemother. 2009 Dec;64(6):1260-4. Epub 2009 Sep 22.PMID: 19776037 [PubMed - in process]Related articles

[Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1.]

Oyagüez I, Casado MA, Cotarelo M, Ramírez-Arellano A, Mallolas J.

Farm Hosp. 2009 Sep 1;33(5):247-56. Spanish. PMID: 19775575 [PubMed - in process]Related articlesFree article

Efavirenz: a decade of clinical experience in the treatment of HIV.

Maggiolo F.

J Antimicrob Chemother. 2009 Nov;64(5):910-28. Epub 2009 Sep 18.PMID: 19767318 [PubMed - in process]Related articlesFree article

Tenofovir-Emtricitabine-Efavirenz in HIV-1-Infected Adults in Senegal: A 96-Week Pilot Trial in Treatment-Naive Patients.

Landman R, Poupard M, Diallo M, Gueye NF, Diakhate N, Ndiaye B, Kane CT, Trylesinski A, Diop H, Mboup S, Fall MB, Deleporte E, Benalycherif AD, Girard PM, Sow PS.

J Int Assoc Physicians AIDS Care (Chic Ill). 2009 Sep 15. [Epub ahead of print]PMID: 19755618 [PubMed - as supplied by publisher]Related articles

Efficacy and safety of atazanavir-ritonavir plus abacavir-lamivudine or tenofovir-emtricitabine in patients with hyperlipidaemia switched from a stable protease inhibitor-based regimen including one thymidine analogue.

Calza L, Manfredi R, Colangeli V, Pocaterra D, Rosseti N, Pavoni M, Chiodo F.

AIDS Patient Care STDS. 2009 Sep;23(9):691-7.PMID: 19739937 [PubMed - indexed for MEDLINE]Related articles

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

Gaffney MM, Belliveau PP, Spooner LM.

Ann Pharmacother. 2009 Oct;43(10):1676-83. Epub 2009 Sep 8.PMID: 19737995 [PubMed - in process]Related articles